Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
8.19
+0.06 (0.74%)
Mar 9, 2026, 2:12 PM EDT - Market open
Lipocine Market Cap
Lipocine has a market cap or net worth of $45.47 million as of March 9, 2026. Its market cap has increased by 136.82% in one year.
Market Cap
45.47M
Enterprise Value
29.77M
1-Year Change
136.82%
Ranking
Category
Stock Price
$8.19
Market Cap Chart
Since March 21, 2014, Lipocine's market cap has decreased from $82.30M to $45.47M, a decrease of -44.75%. That is a compound annual growth rate of -4.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 45.10M | 1.12% |
| Dec 31, 2025 | 44.60M | 70.88% |
| Dec 31, 2024 | 26.10M | 76.35% |
| Dec 29, 2023 | 14.80M | -57.95% |
| Dec 30, 2022 | 35.20M | -59.77% |
| Dec 31, 2021 | 87.50M | -2.02% |
| Dec 31, 2020 | 89.30M | 811.22% |
| Dec 31, 2019 | 9.80M | -64.87% |
| Dec 31, 2018 | 27.90M | -61.73% |
| Dec 29, 2017 | 72.90M | 8.48% |
| Dec 30, 2016 | 67.20M | -71.53% |
| Dec 31, 2015 | 236.00M | 250.67% |
| Dec 31, 2014 | 67.30M | -18.23% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Klotho Neurosciences | 49.57M |
| LeonaBio | 49.48M |
| Acrivon Therapeutics | 48.91M |
| MiNK Therapeutics | 48.26M |
| Estrella Immunopharma | 44.98M |
| NextCure | 43.43M |
| Apollomics | 43.05M |
| Telomir Pharmaceuticals | 42.98M |